Flood J F, Cherkin A
Psychobiology Research Laboratory, Veterans Administration Hospital, Sepulveda, CA 91343.
Neurobiol Aging. 1988 Jan-Feb;9(1):5-8. doi: 10.1016/s0197-4580(88)80003-4.
The amnesias characteristic of Alzheimer's disease and other age-related dementias are refractory to conventional pharmacotherapy. A recent treatment strategy is to combine drugs to improve their memory enhancing effect. We previously reported that in young weakly trained mice, the combination of arecoline and tacrine was more effective on a mg/kg basis than either drug administered alone. This was true whether the route of administration was intracerebroventricular, subcutaneous or oral. We now report that 24 month old mice trained to avoid footshock in a T-maze show poor retention when tested one week later. Subcutaneous administration of arecoline, tacrine (also referred to as tetrahydroaminoacridine, THA) and arecoline plus tacrine administered immediately after T-maze footshock avoidance training enhanced retention of 24 month old mice compared to the saline-injected control. Since the combination was as effective as the single drug treatments even though 96% less arecoline and 99.7% less tacrine was administered, the combination showed marked potentiation of drug action of memory processing.
阿尔茨海默病及其他与年龄相关的痴呆症所特有的失忆症对传统药物治疗具有抗性。最近的一种治疗策略是联合用药以提高其记忆增强效果。我们之前报道过,在年轻且训练不足的小鼠中,按毫克/千克计算,槟榔碱和他克林联合使用比单独使用任一药物更有效。无论给药途径是脑室内、皮下还是口服,都是如此。我们现在报道,在T迷宫中接受避免足部电击训练的24月龄小鼠,在一周后测试时表现出较差的记忆保持能力。与注射生理盐水的对照组相比,在T迷宫足部电击避免训练后立即皮下注射槟榔碱、他克林(也称为四氢氨基吖啶,THA)以及槟榔碱加他克林,可增强24月龄小鼠的记忆保持能力。由于联合用药即使使用的槟榔碱减少了96%,他克林减少了99.7%,但其效果仍与单一药物治疗相同,因此联合用药显示出对记忆处理药物作用的显著增强。